John G. Saia - 15 Apr 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Chief Legal Officer
Signature
/s/ John G. Saia
Issuer symbol
GH
Transactions as of
15 Apr 2023
Transactions value $
-$90,454
Form type
4
Filing time
17 Apr 2023, 17:43:46 UTC
Previous filing
03 Mar 2023
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +7.57K +54.04% $0.00 21.6K 15 Apr 2023 Direct
transaction GH COMMON STOCK Tax liability -$64.1K -2.62K -12.14% $24.50 19K 15 Apr 2023 Direct F1
transaction GH COMMON STOCK Tax liability -$26.3K -1.07K -5.67% $24.50 17.9K 15 Apr 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -7.57K -25% $0.00 22.7K 15 Apr 2023 COMMON STOCK 7.57K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock units granted on August 8, 2022 vests over a four-year period. 25% of the shares subject to such award will vest on the one-year anniversary of April 15, 2022, and the remaining 75% annually during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.